International Journal of Endocrinology

Research Article

Serum Zinc-α2-Glycoprotein Levels in Patients with or without Coronary Artery Disease in Chinese North Population

Table 1

The demographic, clinical, and laboratory characteristics of CAD, NCAD subjects and controls.


Characteristics	Control group (n = 121)	NCAD group (n = 99)	CAD group (n = 129)

Age (years)	44.50 ± 12.97	60.12 ± 10.09^a	61.03 ± 10.51^a
Sex (M/F)	43/78	53/46^a	75/54^a
BMI (kg/m²)	26.44 ± 3.41	25.94 ± 3.74	25.88 ± 3.50
SBP (mmHg)	125.09 ± 18.70	129.82 ± 14.98	131.88 ± 18.35^a
DBP (mmHg)	79.13 ± 11.77	76.46 ± 12.26	76.08 ± 12.03^a
FBG (mmol/L)	5.36 ± 0.86	6.76 ± 2.48^a	8.48 ± 3.77^ab
TC (mmol/L)	4.81 ± 0.85	4.20 ± 0.97^a	4.28 ± 1.09^a
TG (mmol/L)	1.41 (0.87, 1.87)	1.28 (1.03, 1.87)	1.51 (1.07, 2.17)
HDL-C (mmol/L)	1.40 ± 0.36	1.08 ± 0.29^a	1.02 ± 0.25^a
LDL-C (mmol/L)	2.93 ± 0.70	2.42 ± 0.75^a	2.55 ± 0.85^a
TC/HDL-C	3.56 ± 0.93	4.02 ± 1.07^a	4.34 ± 1.22^a
LDL-C/HDL-C	2.20 ± 0.80	2.33 ± 0.76	2.61 ± 0.92^ab
ALT (U/L)	19.00 (14.00, 25.00)	23.00 (16.00, 35.00)^a	23.00 (17.00, 39.00)^a
Cr (μmol/L)	74.00 (58.00, 93.00)	74.00 (64.00, 84.00)	76.00 (65.00, 88.00)
Urea (mmol/L)	4.93 (4.00, 6.03)	5.15 (4.56, 6.58)	5.84 (4.81, 7.27)^a
Hypertension (%)	0	65/99 (65.66)	94/129 (72.87)
Type 2 diabetes mellitus (%)	0	28/99 (28.28)	65/129 (50.39)^b
Hyperlipidemia (%)	0	53/99 (53.54)	84/129 (65.12)
Hypotensive drugs (%)	0	56/99 (56.57)	79/129 (61.24)
Hypoglycemic drugs (%)	0	18/99 (18.18)	40/129 (31.01)^b
Insulin (%)	0	5/99 (5.05)	11/129 (8.53)

M: male; F: female; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; TC: total cholesterol; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; ALT: alanine transaminase; Cr: creatinine; NCAD: noncoronary artery disease; CAD: coronary artery disease. Data were expressed as mean ± SD or median with interquartile range. compared with the control group; compared with the NCAD group.